Detalhe da pesquisa
1.
Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline.
Eur J Clin Pharmacol
; 75(11): 1541-1545, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402421
2.
Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
BMC Med Genet
; 19(1): 55, 2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29621993
3.
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
BMC Cardiovasc Disord
; 16: 2, 2016 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26728720
4.
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy.
Eur J Clin Pharmacol
; 71(9): 1067-73, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153084
5.
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion.
Front Pharmacol
; 13: 900112, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35935834
6.
Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment.
Genes (Basel)
; 11(7)2020 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32640505
7.
Effects of aging on the effectiveness of smoking cessation medication.
Oncotarget
; 7(21): 30032-6, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27166253